KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
81 hedge funds and large institutions have $314M invested in Kindred Biosciences, Inc. in 2018 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
39% more capital invested
Capital invested by funds: $226M → $314M (+$88M)
11% more funds holding
Funds holding: 73 → 81 (+8)
Holders
81
Holding in Top 10
2
Calls
$252K
Puts
$155K
Top Buyers
| 1 | +$7.03M | |
| 2 | +$4.37M | |
| 3 | +$3.5M | |
| 4 |
Invesco
Atlanta,
Georgia
|
+$2.75M |
| 5 |
SAM
Silverback Asset Management
Chapel Hill,
North Carolina
|
+$2.07M |
Top Sellers
| 1 | -$2.82M | |
| 2 | -$2.15M | |
| 3 | -$1.9M | |
| 4 |
AFS
Amtrust Financial Services
New York
|
-$1.08M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$1.06M |